Comparison of PD‐L1 detection assays and corresponding significance in evaluation of diffuse large B‐cell lymphoma

The expression of programmed cell death ligand 1 (PD‐L1) is a biomarker for immunotherapy, but approved detection method is absent in diffuse large B‐cell lymphoma (DLBCL). Here, we performed three methods including immunohistochemistry (IHC) (clone SP263 and SP142), RNAscope, and fluorescence in si...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Sixia, Nong, Lin, Liang, Li, Zheng, Yalin, Wang, Wei, Liu, Jumei, Li, Dong, Li, Xin, Wang, Ying, Zhang, Bo, Li, Ting
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639200/
https://www.ncbi.nlm.nih.gov/pubmed/31150165
http://dx.doi.org/10.1002/cam4.2316

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639200/
https://www.ncbi.nlm.nih.gov/pubmed/31150165
http://dx.doi.org/10.1002/cam4.2316

Ejemplares similares